24 October 2025
: Case report 
Medical Management of an Infusion Site Extravasation Injury After Peripheral Intravenous Infusion of Ado-Trastuzumab Emtansine in a 38-Year-Old Woman With Breast Cancer: A Case Report
Unusual clinical course, Adverse events of drug therapy
Eleni M. Gamvroulas BDEF 1*, Patricia Jeppson E 1, Mei Wei
ADEF 2
DOI: 10.12659/AJCR.949828
Am J Case Rep 2025; 26:e949828
Figure 6 A 38-year-old woman with infusion site extravasation injury following intravenous treatment with TDM1. At 28 days after the initial insult, the wound is almost fully resolved. One small scab remains. There is no swelling remaining. The erythema is almost entirely improved, although some hyperpigmentation remains.